CDMO Cambrex has begun construction on a new R&D facility in Milan, Italy, a $30 million investment will add advanced analytical development and process R&D capabilities, alongside upgrades to multiple production plants. The Milan R&D expansion is expected to be completed in the second half of 2027. To accommodate future… Read More
Jessica Del Vecchio, Economic Development Manager for The Office of Economic Development in the City of Boca Raton, asks how permitting assistance … Read More
Jesper Frank Bastlund, Senior Director in Biological and Translational Research, and Enchi Liu, Vice President, Head of Experimental Medicine at Lundbeck, examine how biomarkers can help advance… Read More
To celebrate Research Appreciation Day 2025 on 5 July, DDW’s Diana Turner has collated the best career advice from our Meet the Researcher interviewees over the last year. Enjoy what you do “It is important to enjoy what you do, as it takes a lot of your time and… Read More
The UK could lose out on £11 ($14.8) billion in pharmaceuticals research and development (R&D) investment by 2033, according to WPI Economics. In the UK, the Voluntary Scheme or VPAG requires companies to pay the Department of Health and Social Care (DHSC) up to a quarter to… Read More
US President Donald Trump has signed an Executive Order calling for large cuts to the prices of drugs in the United States (US), to better match the prices paid by other countries. The move has caused fluctuations in stock prices for pharmaceutical companies and is likely to… Read More
European Commission President Ursula von der Leyen has announced new funding ‘super grants’ at the ‘Choose Europe for Science’ conference. The substantial additional budget for the development of larger, longer-term grants has been welcomed by the Scientific Council of the European Research Council (ERC). As… Read More
Aviva Capital Partners (ACP) and developer Socius have unveiled plans for a new £1 ($1.3) billion development to create a leading centre for cancer research in Sutton, London, UK. The development will be delivered on a 12-acre site at the London Cancer Hub, adjacent to The Institute… Read More
Wellcome has announced plans to partner with the UK Government to establish a new health data research service. The new service, backed by £100 million from Wellcome and up to £500 million from the UK Government, will give approved researchers a single secure route to health data… Read More
This is the latest episode of the free DDW narrated podcast, titled “Getting to know key drug discovery leaders”, which covers two articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: “Sitting down with… Neil Dhawan”, “Meet the researcher: Giusy Di Conza, iOnctura”… Read More
The UK Department for Science, Innovation and Technology (DSIT) has set out how it will allocate £13.9 ($17.9) billion in funding for transformational research and development in the next year in areas like life sciences, green energy, engineering and beyond. UK Research and Innovation (UKRI) – the… Read More
It seems rather obvious, and somewhat unfair to DDW’s readers – considering how much he has been in the news recently – to talk more about President Donald Trump and specifically his decision to cut billions of dollars in funding to the National Institutes of Health (NIH). The decision… Read More
Pharma R&D is transitioning toward an AI/data driven model of drug discovery, and great progress has been made in the last 20 years. To fully exploit the potential of this technology we must think holistically about how it is integrated into R&D. Fit-for-purpose data is essential, as are models that… Read More
Friday the 5th of July is Research Appreciation Day, which was launched by MQ Mental Health Research in 2023 to celebrate the hard work of health researchers and scientists around the world. MQ Mental Health Research says: “This year we are celebrating the incredible breakthroughs made… Read More
The Francis Crick Institute in the UK has announced the inception of six partnerships with small and medium-sized enterprises (SMEs), focussed on the application of novel technologies to discovery projects led by Crick researchers. The collaborations are supported by a Business Engagement Fund award from the… Read More
Takara Bio has launched PrimeCap T7 RNA Polymerase (low dsRNA), a mutant T7 RNA polymerase suitable for mRNA therapeutic research and development. PrimeCap T7 RNA Polymerase is a mutant T7 RNA polymerase that has been genetically engineered to maintain high-performance RNA synthesis activity while reducing dsRNA… Read More
